ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 48 filers reported holding ENZO BIOCHEM INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,724,505 | +87986.2% | 2,499,546 | +2.6% | 0.01% | 0.0% |
Q1 2024 | $3,093 | -10.2% | 2,435,129 | -1.8% | 0.01% | 0.0% |
Q4 2023 | $3,446 | -3.7% | 2,479,195 | -3.0% | 0.01% | -16.7% |
Q3 2023 | $3,578 | -28.1% | 2,556,064 | -5.5% | 0.01% | -14.3% |
Q2 2023 | $4,977 | -26.1% | 2,704,864 | -2.4% | 0.01% | -22.2% |
Q1 2023 | $6,731 | +67.3% | 2,770,064 | -1.6% | 0.01% | +50.0% |
Q4 2022 | $4,024 | -99.9% | 2,813,964 | -3.3% | 0.01% | -33.3% |
Q3 2022 | $6,489,000 | +3.9% | 2,909,664 | -3.5% | 0.01% | +28.6% |
Q2 2022 | $6,243,000 | -28.5% | 3,016,164 | +0.2% | 0.01% | -30.0% |
Q1 2022 | $8,732,000 | -12.1% | 3,011,164 | -2.7% | 0.01% | -16.7% |
Q4 2021 | $9,934,000 | -12.6% | 3,094,764 | -3.6% | 0.01% | -20.0% |
Q3 2021 | $11,364,000 | +10.0% | 3,210,064 | -1.5% | 0.02% | +15.4% |
Q2 2021 | $10,332,000 | -10.1% | 3,259,264 | -2.4% | 0.01% | -7.1% |
Q1 2021 | $11,493,000 | +28.2% | 3,340,864 | -6.1% | 0.01% | +40.0% |
Q4 2020 | $8,962,000 | +18.4% | 3,556,223 | -0.9% | 0.01% | +25.0% |
Q3 2020 | $7,568,000 | -2.5% | 3,586,723 | +3.5% | 0.01% | +14.3% |
Q2 2020 | $7,762,000 | -7.4% | 3,465,278 | +4.6% | 0.01% | -12.5% |
Q1 2020 | $8,379,000 | -5.0% | 3,311,978 | -1.2% | 0.01% | +14.3% |
Q4 2019 | $8,821,000 | -25.7% | 3,353,808 | +1.6% | 0.01% | -30.0% |
Q3 2019 | $11,878,000 | +8.4% | 3,299,563 | +1.5% | 0.01% | 0.0% |
Q2 2019 | $10,956,000 | +26.0% | 3,251,033 | +2.1% | 0.01% | +25.0% |
Q1 2019 | $8,696,000 | +1.3% | 3,185,229 | +3.2% | 0.01% | -11.1% |
Q4 2018 | $8,584,000 | -29.7% | 3,087,670 | +4.2% | 0.01% | -30.8% |
Q3 2018 | $12,206,000 | -61.7% | 2,962,700 | -50.4% | 0.01% | -23.5% |
Q2 2018 | $31,894,000 | +95.5% | 5,979,100 | +100.8% | 0.02% | -5.6% |
Q1 2018 | $16,313,000 | -14.3% | 2,976,900 | +27.4% | 0.02% | -14.3% |
Q4 2017 | $19,037,000 | -15.0% | 2,335,800 | +9.3% | 0.02% | -19.2% |
Q3 2017 | $22,384,000 | -2.0% | 2,137,900 | +3.3% | 0.03% | -10.3% |
Q2 2017 | $22,848,000 | +33.7% | 2,069,600 | +1.3% | 0.03% | +20.8% |
Q1 2017 | $17,095,000 | +25.3% | 2,042,400 | +3.9% | 0.02% | +9.1% |
Q4 2016 | $13,641,000 | +36.9% | 1,965,500 | +0.4% | 0.02% | +22.2% |
Q3 2016 | $9,963,000 | -10.6% | 1,957,368 | +4.8% | 0.02% | -14.3% |
Q2 2016 | $11,146,000 | +69.0% | 1,866,981 | +28.8% | 0.02% | +61.5% |
Q1 2016 | $6,597,000 | +17.0% | 1,449,900 | +15.7% | 0.01% | +8.3% |
Q4 2015 | $5,639,000 | +59.8% | 1,253,100 | +12.6% | 0.01% | +50.0% |
Q3 2015 | $3,529,000 | -1.3% | 1,113,200 | -5.7% | 0.01% | 0.0% |
Q2 2015 | $3,576,000 | -0.1% | 1,180,152 | -2.8% | 0.01% | 0.0% |
Q1 2015 | $3,580,000 | -14.6% | 1,213,643 | +28.5% | 0.01% | -20.0% |
Q4 2014 | $4,193,000 | -12.3% | 944,337 | +1.7% | 0.01% | -23.1% |
Q3 2014 | $4,783,000 | +61.6% | 928,800 | +64.7% | 0.01% | +85.7% |
Q2 2014 | $2,960,000 | +58.9% | 563,818 | +25.9% | 0.01% | +75.0% |
Q1 2014 | $1,863,000 | +84.6% | 447,881 | +29.6% | 0.00% | +100.0% |
Q4 2013 | $1,009,000 | +41.1% | 345,637 | +21.7% | 0.00% | 0.0% |
Q3 2013 | $715,000 | +32.9% | 283,900 | +9.8% | 0.00% | +100.0% |
Q2 2013 | $538,000 | – | 258,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBERT FUND ADVISORS, INC. | 5,620,681 | $20,234,000 | 30.10% |
Evermore Global Advisors, LLC | 4,007,851 | $14,428,000 | 3.48% |
Fondren Management LP | 355,000 | $1,278,000 | 1.06% |
CORRADO ADVISORS, LLC | 196,309 | $707,000 | 0.64% |
MARATHON CAPITAL MANAGEMENT | 193,580 | $697,000 | 0.28% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $344,000 | 0.23% |
EAM Investors, LLC | 203,962 | $734,000 | 0.19% |
Ariel Investments | 1,026,313 | $3,695,000 | 0.05% |
HighVista Strategies LLC | 19,500 | $70,000 | 0.05% |
Paradigm Financial Partners, LLC | 17,175 | $60,000 | 0.03% |